Nearly 90% of biotech stocks are losing money, but that doesn’t mean our healthcare analysts don’t perceive there to be value in the sector.
Nearly 90% of biotech stocks are losing money, but that doesn’t mean our healthcare analysts don’t perceive there to be value in the sector.